Oversea Chinese Banking Corp LTD Biogen Inc. Transaction History

Oversea Chinese Banking Corp LTD

  • $3.74 Billion
  • Q3 2025

A detailed history of Oversea Chinese Banking Corp LTD transactions in Biogen Inc. stock. As of the latest transaction made, Oversea Chinese Banking Corp LTD holds 46,203 shares of BIIB stock, worth $6.91 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
46,203
Previous 45,980 0.48%
Holding current value
$6.91 Million
Previous $5.77 Million 12.09%
% of portfolio
0.17%
Previous 0.17%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025
BUY
$122.68 - $148.84 $27,357 - $33,191
223 Added 0.48%
46,203 $6.47 Million
Q2 2025

Jul 31, 2025
SELL
$113.38 - $135.49 $827,674 - $989,077
-7,300 Reduced 13.7%
45,980 $5.77 Million
Q1 2025

May 08, 2025
SELL
$133.43 - $153.27 $97 Million - $111 Million
-727,287 Reduced 93.17%
53,280 $7.29 Million
Q1 2025

May 01, 2025
BUY
$133.43 - $153.27 $98.2 Million - $113 Million
736,301 Added 1663.36%
780,567 $107 Million
Q4 2024

Feb 10, 2025
BUY
$146.47 - $191.55 $4.18 Million - $5.46 Million
28,524 Added 181.2%
44,266 $6.77 Million
Q3 2024

Nov 04, 2024
BUY
$189.07 - $236.8 $594,625 - $744,736
3,145 Added 24.97%
15,742 $3.05 Million
Q2 2024

Aug 05, 2024
BUY
$190.52 - $236.72 $3,048 - $3,787
16 Added 0.13%
12,597 $2.92 Million
Q1 2024

May 13, 2024
BUY
$212.02 - $267.71 $171,948 - $217,112
811 Added 6.89%
12,581 $2.71 Million
Q4 2023

May 21, 2024
SELL
$222.59 - $267.94 $180,520 - $217,299
-811 Reduced 6.45%
11,770 $3.05 Million
Q4 2023

Jan 31, 2024
BUY
$222.59 - $267.94 $166,942 - $200,955
750 Added 6.81%
11,770 $3.05 Million
Q3 2023

Apr 29, 2024
SELL
$253.3 - $285.89 $189,975 - $214,417
-750 Reduced 6.37%
11,020 $2.83 Million
Q3 2023

Nov 03, 2023
BUY
$253.3 - $285.89 $347,021 - $391,669
1,370 Added 14.2%
11,020 $2.83 Million
Q1 2023

Sep 15, 2023
BUY
$256.56 - $292.34 $56,443 - $64,314
220 Added 2.33%
9,650 $2.68 Million
Q1 2023

May 08, 2023
BUY
$256.56 - $292.34 $56,443 - $64,314
220 Added 2.33%
9,650 $2.68 Million
Q4 2022

Sep 15, 2023
SELL
$252.44 - $306.72 $55,536 - $67,478
-220 Reduced 2.28%
9,430 $2.61 Million
Q4 2022

Feb 13, 2023
BUY
$252.44 - $306.72 $2.38 Million - $2.89 Million
9,430 New
9,430 $0

Others Institutions Holding BIIB

# of Institutions
1,036
Shares Held
131M
Call Options Held
2.84M
Put Options Held
2.54M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Oversea Chinese Banking Corp LTD Portfolio

Follow Oversea Chinese Banking Corp LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oversea Chinese Banking Corp LTD, based on Form 13F filings with the SEC.

News

Stay updated on Oversea Chinese Banking Corp LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email